A Bengaluru event billed as India’s first “Peptide Party” was cancelled after the Karnataka Food Safety and Drug Administration (FSDA) issued a notice to its organisers, seeking detailed information about the peptide preparations that were to be featured at the gathering.

The invite-only event, organised by Upsurge Labs LLP, was scheduled for August 29 in Bengaluru’s Koramangala and had been promoted as a combination of “peptide tastings”, music, food and networking. The regulatory intervention has brought attention to a growing wellness and biohacking subculture centred on peptide-based products, some of which may be unapproved or subject to drug regulations.

What is a ‘Peptide Party’?

A “Peptide Party” is a niche social gathering where biohackers, wellness enthusiasts and fitness influencers come together to discuss, sample or promote peptide-based products.

Such events are often presented as exclusive health, fitness and longevity gatherings, combining networking and social activities with discussions or demonstrations involving peptides. Some peptides are promoted online for purported benefits including weight management, muscle growth, faster recovery and anti-ageing.

Peptides themselves are not a single drug or substance. They are short chains of amino acids that perform different functions in the human body. However, the safety and regulatory status of an individual peptide depends on factors including its composition, intended use, claims made about it and how it is administered.

This distinction has become a key concern for regulators because certain peptide preparations may fall within the regulatory framework applicable to drugs.

Why did the Bengaluru event attract regulatory attention?

The FSDA said the matter came to its notice through social media publicity for the proposed event in Koramangala. According to the department, the promotional material appeared to indicate that peptide preparations or products could be made available to participants.

“The publicity material appears to indicate that peptide preparations/products may be promoted, displayed, supplied, distributed, recommended, administered or otherwise made available to participants in connection with the proposed event,” it said in a notice to the organisers of the event.

The department said the exact identity, composition, source, regulatory classification, intended use and regulatory status of the preparations mentioned in the publicity material had not been established.

The FSDA therefore sought information on the individual peptide products, their manufacturers and sources, as well as import details and relevant regulatory licences.

It also asked the organisers to provide details of claims relating to weight management, muscle growth and other purported benefits, along with scientific evidence and regulatory approvals supporting those claims.

FSDA seeks information on medical supervision and adverse-event management

The regulator also sought details about medical supervision and consent procedures, as well as arrangements to deal with any adverse events if peptides were to be administered to participants.

The concerns are particularly relevant because some peptide products marketed in wellness and biohacking circles may be used without adequate medical oversight. Depending on the substance and method of administration, potential risks can include allergic reactions, contamination, hormonal effects and other adverse health outcomes.

The regulatory questions therefore went beyond the event’s promotional description and focused on what products were actually intended to be presented, supplied or administered to attendees.

Event cancelled after FSDA notice

The event was eventually called off after the FSDA sought information from the organisers.

“The authorised representatives of Upsurge Labs LLP, the organisers of the event, after an enquiry, have communicated that the scheduled event stands cancelled,” the FSDA said.

According to the department, the organisers had been asked to submit documents concerning the event and were given suitable time to produce them.

The FSDA also issued an advisory to the public informing them that the August 29 event had been cancelled.

The organisers later said there was no injectable or prescription material planned for the event. They said the FSDA had reached out “under due process of law” and that they were “cooperating fully” with the regulator’s office.

Why are peptide parties a concern?

The Bengaluru episode highlights the regulatory questions surrounding a wellness trend that has increasingly intersected with biohacking, fitness and longevity culture.

While peptides have legitimate medical and biological applications, the term covers a broad range of substances with very different properties and regulatory statuses. Concerns arise when products are promoted for medical or cosmetic benefits without established approvals, adequate scientific evidence or appropriate medical supervision.

The FSDA’s intervention underscores the importance of establishing what a peptide product contains, where it comes from, how it is intended to be used and whether it is legally authorised before it is supplied or administered to consumers.

For the Bengaluru event, those questions remained central to the regulator’s inquiry, ultimately resulting in its cancellation.